Clarus Therapeutics Announces Commercial Launch and Availability of JATENZO® (testosterone undecanoate) capsules, CIII for the Treatment of Hypogonadism

NEXT STORY
SELLAS Names Dragan Cicic, MD, as Senior Vice President, Clinical Development
PREV STORY
Global Medical Tubing Markets to 2025: Forecast by Product (Silicone, Polyolefins), Application (Bulk Disposable Tubing, Catheters, Drug Delivery Systems) and Region
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Innovation Pharmaceuticals Provides Development Update on Brilacidin for Inflammatory Bowel Disease

BEVERLY, Mass., Oct. 24, 2017 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals Inc. (OTCQB:IPIX) (“the Company”), ...

author_avatar
NASDAQ Market News

Ascendis Pharma A/S Receives Orphan Designation for TransCon™ hGH for the Treatment of Pediatric Growth Hormone Deficiency in Europe

author_avatar
NASDAQ Market News

ERYTECH Provides Update on Phase 2 Investigator Sponsored Trial of Eryaspase in Second-Line Acute Lymphoblastic Leukemia

author_avatar
NASDAQ Market News